Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.425 CHF -2.84%
Market Cap: 138.3m CHF

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 9.52 CHF with a low forecast of 5.05 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
5.05 CHF
47% Upside
Average
Price Target
9.52 CHF
178% Upside
Highest
Price Target
15.75 CHF
360% Upside
Molecular Partners AG Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
57% Upside
ACLX
Arcellx Inc
75% Upside
GOSS
Gossamer Bio Inc
180% Upside
ENTA
Enanta Pharmaceuticals Inc
18% Upside
ADAG
Adagene Inc
409% Upside
FYB
Formycon AG
102% Upside
214450
PharmaResearch Co Ltd
97% Upside
APLS
Apellis Pharmaceuticals Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 10 years the compound annual growth rate for Molecular Partners AG's revenue is -15%. The projected CAGR for the next 4 years is 79%.

-15%
Past Growth
79%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
9.52 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 9.52 CHF with a low forecast of 5.05 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
79%

For the last 10 years the compound annual growth rate for Molecular Partners AG's revenue is -15%. The projected CAGR for the next 4 years is 79%.

Back to Top